Anebulo Pharmaceuticals I... (ANEB)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

1.40

-3.11%

After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY24	FY23	FY22	FY21	FY20
Revenue	-	-	-	-	-
Cost of Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
Operating Income	-8.31M	-11.78M	-6.83M	-3.61M	-173.35K
Interest Income	97.79K	92.41K	7.33K	1.02K	7.72
Pretax Income	-8.20M	-11.73M	-6.83M	-30.25M	-174.64K
Net Income	-8.20M	-11.73M	-6.81M	-30.26M	-174.64K
Selling & General & Admin	4.76M	6.18M	3.87M	1.34M	23.35K
Research & Development	3.55M	5.60M	2.96M	2.27M	150.00K
Other Expenses	-	-41.15K	-1.78K	-1.34K	-
Operating Expenses	8.31M	11.78M	6.83M	3.61M	173.35K
Interest Expense	-	-	7.33K	11.77K	1.29K
Selling & Marketing Expenses	4.80K	-	-	-	23.21K
Cost & Expenses	8.31M	11.78M	6.83M	3.61M	173.35K
Income Tax	-	-104.19K	-12.89K	10.75K	-1.04K
Shares Outstanding (Basic)	25.82M	25.07M	23.34M	23.34M	23.72M
Shares Outstanding (Diluted)	25.82M	25.07M	23.34M	23.34M	23.72M
EPS (Basic)	-0.32	-0.47	-0.29	-1.3	-0.01
EPS (Diluted)	-0.32	-0.47	-0.29	-1.3	-0.01
EBITDA	-8.05M	-11.78M	5.55K	-30.24M	-173.35K
Depreciation & Amortization	258.28K	11.78M	6.83M	3.61M	1.04M